RecruitingNot applicableNCT06611072

OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Gynaecologisch Oncologisch Centrum Zuid
Intervention
Bone marrow aspiration(procedure)
Enrollment
90 target
Eligibility
18 years · FEMALE
Timeline
20252027

Study locations (1)

Collaborators

Eindhoven University of Technology · Radboud University Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06611072 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary

← Back to all trials